Novel Advances in Modifying BMPR2 Signaling in PAH

Novel Advances in Modifying BMPR2 Signaling in PAH

Pulmonary Arterial Hypertension (PAH) is a disease of the pulmonary arteries, that is characterized by progressive narrowing of the pulmonary arterial lumen and increased pulmonary vascular resistance, ultimately leading to right ventricular dysfunction, heart failure and premature death. Current tr...

Full description

Bibliographic Details
Main Authors: Svenja Dannewitz Prosseda, Md Khadem Ali, Edda Spiekerkoetter
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Genes
Subjects:
PAH
pulmonary hypertension
bone morphogenetic protein receptor 2
signaling
repurposed drugs
pharmaceuticals
Online Access:https://www.mdpi.com/2073-4425/12/1/8

Internet

https://www.mdpi.com/2073-4425/12/1/8

Similar Items